UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 305

Sortiert nach

An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane

Cancer, 2002-11, Vol.95 (9), p.2006-2016

2002

Volltextzugriff (PDF)

Endocrine therapy in the treatment of metastatic breast cancer

Seminars in oncology, 2001-06, Vol.28 (3), p.291-304, Article asonc0280291

Buzdar, Aman U.

2001

Volltextzugriff (PDF)

Prognostic Value of Pathologic Complete Response After Primary Chemotherapy in Relation to Hormone Receptor Status and Other Factors

Journal of clinical oncology, 2006-03, Vol.24 (7), p.1037-1044

2006

Volltextzugriff (PDF)

Breast carcinoma in men: A population-based study

Cancer, 2004-07, Vol.101 (1), p.51-57

2004

Volltextzugriff (PDF)

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

The Lancet (British edition), 2002-06, Vol.359 (9324), p.2131-2139

2002

Volltextzugriff (PDF)

Outcome After Pathologic Complete Eradication of Cytologically Proven Breast Cancer Axillary Node Metastases Following Primary Chemotherapy

Journal of clinical oncology, 2005-12, Vol.23 (36), p.9304-9311

2005

Volltextzugriff (PDF)

Is breast cancer survival improving? Trends in survival for patients with recurrent breast cancer diagnosed from 1974 through 2000

Cancer, 2004, Vol.100 (1), p.44-52

2004

Volltextzugriff (PDF)

Invasive Lobular Carcinoma Classic Type: Response to Primary Chemotherapy and Survival Outcomes

Journal of clinical oncology, 2005-01, Vol.23 (1), p.41-48

2005

Volltextzugriff (PDF)

Weekly Paclitaxel Improves Pathologic Complete Remission in Operable Breast Cancer When Compared With Paclitaxel Once Every 3 Weeks

Journal of clinical oncology, 2005-09, Vol.23 (25), p.5983-5992

2005

Volltextzugriff (PDF)

Breast cancer in men

Annals of internal medicine, 2002-10, Vol.137 (8), p.678

2002

Volltextzugriff (PDF)

Nomograms to Predict Pathologic Complete Response and Metastasis-Free Survival After Preoperative Chemotherapy for Breast Cancer

Journal of clinical oncology, 2005-11, Vol.23 (33), p.8331-8339

2005

Volltextzugriff (PDF)

'Chemobrain' in breast carcinoma? A prologue

Cancer, 2004-08, Vol.101 (3), p.466-475

2004

Volltextzugriff (PDF)

Postmastectomy Radiation Improves Local-Regional Control and Survival for Selected Patients With Locally Advanced Breast Cancer Treated With Neoadjuvant Chemotherapy and Mastectomy

Journal of clinical oncology, 2004-12, Vol.22 (23), p.4691-4647

2004

Volltextzugriff (PDF)

Adjuvant systemic therapy for male breast carcinoma

Cancer, 2005-12, Vol.104 (11), p.2359-2364

2005

Volltextzugriff (PDF)

Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy

Annals of surgery, 2006-02, Vol.243 (2), p.257-264

2006

Volltextzugriff (PDF)

Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy

Journal of clinical oncology, 1999-02, Vol.17 (2), p.460-469

1999

Volltextzugriff (PDF)

Multicenter Phase II Study of Capecitabine in Paclitaxel-Refractory Metastatic Breast Cancer

Journal of clinical oncology, 1999-02, Vol.17 (2), p.485-493

1999

Volltextzugriff (PDF)

Advances in Endocrine Treatments for Postmenopausal Women with Metastatic and Early Breast Cancer

The oncologist (Dayton, Ohio), 2003-01, Vol.8 (4), p.335-341

Buzdar, Aman U.

2003

Volltextzugriff (PDF)

Locoregional Recurrence Patterns After Mastectomy and Doxorubicin-Based Chemotherapy: Implications for Postoperative Irradiation

Journal of clinical oncology, 2000-08, Vol.18 (15), p.2817-2827

2000

Volltextzugriff (PDF)

Estrogen receptors and distinct patterns of breast cancer relapse

Breast cancer research and treatment, 2003-03, Vol.78 (1), p.105-118

2003

Volltextzugriff (PDF)

Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response

Cancer, 2004-04, Vol.100 (7), p.1365-1373

2004

Volltextzugriff (PDF)

Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers

Annals of oncology, 2007-05, Vol.18 (5), p.874-880

2007

Volltextzugriff (PDF)

Update on the Management of Inflammatory Breast Cancer

The oncologist (Dayton, Ohio), 2003-01, Vol.8 (2), p.141-148

2003

Volltextzugriff (PDF)

Sentinel Lymph Node Biopsy Is Accurate After Neoadjuvant Chemotherapy for Breast Cancer

Journal of clinical oncology, 2000-10, Vol.18 (20), p.3480-3486

2000

Volltextzugriff (PDF)

1 – 25 von 305

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(279)
Mit Volltextzugriff
(253)

Publikationsform

Artikel
(302)
magazinearticle
(3)

Sprache

Englisch
(305)
Japanisch
(37)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(299)
Science & Technology
(299)
Humans
(289)
Female
(261)
Oncology
(250)
Middle Aged
(197)
Breast Neoplasms - Drug Therapy
(195)
Biological And Medical Sciences
(160)
Adult
(159)
Medical Sciences
(158)
Aged
(140)
Breast Neoplasms - Pathology
(103)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(102)
Chemotherapy
(99)
Pharmacology. Drug Treatments
(93)
Antineoplastic Agents
(85)
Doxorubicin - Administration & Dosage
(64)
Neoplasm Metastasis
(61)
Tumors
(61)
Breast Cancer
(57)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane

Endocrine therapy in the treatment of metastatic breast cancer

Prognostic Value of Pathologic Complete Response After Primary Chemotherapy in Relation to Hormone Receptor Status and Other Factors

Breast carcinoma in men: A population-based study

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

Outcome After Pathologic Complete Eradication of Cytologically Proven Breast Cancer Axillary Node Metastases Following Primary Chemotherapy

Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer

Is breast cancer survival improving? Trends in survival for patients with recurrent breast cancer diagnosed from 1974 through 2000

Invasive Lobular Carcinoma Classic Type: Response to Primary Chemotherapy and Survival Outcomes

Weekly Paclitaxel Improves Pathologic Complete Remission in Operable Breast Cancer When Compared With Paclitaxel Once Every 3 Weeks

Breast cancer in men

Nomograms to Predict Pathologic Complete Response and Metastasis-Free Survival After Preoperative Chemotherapy for Breast Cancer

'Chemobrain' in breast carcinoma? A prologue

Postmastectomy Radiation Improves Local-Regional Control and Survival for Selected Patients With Locally Advanced Breast Cancer Treated With Neoadjuvant Chemotherapy and Mastectomy

Adjuvant systemic therapy for male breast carcinoma

Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy

Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy

Multicenter Phase II Study of Capecitabine in Paclitaxel-Refractory Metastatic Breast Cancer

Advances in Endocrine Treatments for Postmenopausal Women with Metastatic and Early Breast Cancer

Locoregional Recurrence Patterns After Mastectomy and Doxorubicin-Based Chemotherapy: Implications for Postoperative Irradiation

Estrogen receptors and distinct patterns of breast cancer relapse

Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response

Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers

Update on the Management of Inflammatory Breast Cancer

Sentinel Lymph Node Biopsy Is Accurate After Neoadjuvant Chemotherapy for Breast Cancer

Suchergebnisse filtern